ADAM metallopeptidase with thrombospondin type 1 motif 2 inactivation reduces the extent and stability of carbon tetrachloride–induced hepatic fibrosis in mice†
Version of Record online: 10 OCT 2007
Copyright © 2007 American Association for the Study of Liver Diseases
Volume 46, Issue 5, pages 1620–1631, November 2007
How to Cite
Kesteloot, F., Desmoulière, A., Leclercq, I., Thiry, M., Arrese, J. E., Prockop, D. J., Lapière, C. M., Nusgens, B. V. and Colige, A. (2007), ADAM metallopeptidase with thrombospondin type 1 motif 2 inactivation reduces the extent and stability of carbon tetrachloride–induced hepatic fibrosis in mice. Hepatology, 46: 1620–1631. doi: 10.1002/hep.21868
Potential conflict of interest: Dr. Prockop owns stock in FibroGen.
- Issue online: 29 OCT 2007
- Version of Record online: 10 OCT 2007
- Manuscript Accepted: 11 JUN 2007
- Manuscript Received: 22 DEC 2006
- Belgian Fonds National de la Recherche Scientifique (Télévie grants). Grant Numbers: 7.4541.01, 7.4561.03, 7.4566.05
- Belgian Fonds de la Recherche Scientifique Médicale. Grant Numbers: 3.4362.03, 3.4387.05
- Belgian Federation Against Cancer (nonprofit organization)
- European Commission through the Sixth Framework Programme for CORNEA ENGINEERING. Grant Number: contract NMP2-CT-2003-504017
- Région Wallonne through the Réseaux Programme for FIBROMED. Grant Number: contract 415907
Supplementary material for this article can be found on the H EPATOLOGY Web site ( http://interscience.wiley.com/jpages/0270-9139/suppmat/index.html ).
|jws-hep.21868.tbl1.pdf||100K||Supplementary table 1. Primer sequences and number of cycles used for quantification of mouse hepatic mRNA levels by RT-PCR.|
|jws-hep.21868.fig1.pdf||62K||Supplementary fig. 1. Supporting information|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.